|
| 前列腺癌雄激素剥夺治疗与骨质丢失 |
| Androgen deprivation therapy for prostate cancer and bone loss |
| |
| DOI： |
| 中文关键词: 前列腺癌 雄激素剥夺治疗 雄激素；骨质丢失 |
| 英文关键词:Prostate cancer Androgen deprivation therapy Androgen Bone loss |
| 基金项目: |
|
| 摘要点击次数: 1024 |
| 全文下载次数: 1312 |
| 中文摘要: |
| 目的前列腺癌是男性泌尿系统常见的恶性肿瘤之一。我国前列腺癌的发病率在迅速上升。 目前绝大多数患者采取雄激素剥夺治疗，与化疗相比，雄激素剥夺治疗的毒副作用较轻，更容易被患 者接受，但仍会引起一系列的不良反应，本文将对前列腺癌雄激素剥夺治疗后骨质丢失的情况及防治 策略进行综述。 |
| 英文摘要: |
| Prostate cancer is one of the common malignant tumors of the urinary system in the male. The incidence of prostate cancer in China is rising rapidly. At present，the vast majority of patients are receiving androgen deprivation therapy (ADT). Compared with chemotherapy, ADT has less toxic side effect, and it is more likely to be accepted by patients. However, ADT causes a range of adverse reactions. This paper reviews the risk of bone loss after ADT and the prevention and treatment strategies in patients with prostate cancer. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |